MT-RNR2 and cancer: As a mitochondrial-derived peptide encoded within the 16S rRNA region, SHLP6 has dual functionality, exhibiting pro-apoptotic activity in cancer cells and cytoprotective effects in normal cells, making it suitable for targeted therapies (Li et al., 2024).